MDRA Stock Overview
Medra Corporation engages in the acquisition, development, and commercial exploitation of hydrogen-based technologies.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Medra Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.000001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
MDRA | US Electronic | US Market | |
---|---|---|---|
7D | 0% | 2.7% | 2.0% |
1Y | n/a | 20.4% | 22.3% |
Return vs Industry: Insufficient data to determine how MDRA performed against the US Electronic industry.
Return vs Market: Insufficient data to determine how MDRA performed against the US Market.
Price Volatility
MDRA volatility | |
---|---|
MDRA Average Weekly Movement | n/a |
Electronic Industry Average Movement | 7.0% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MDRA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MDRA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | n/a | John Donohue | n/a |
Medra Corporation engages in the acquisition, development, and commercial exploitation of hydrogen-based technologies. The company primarily concentrates on fuel cells, hydrogen-specific sensors, and hydrogen safety. It seeks out technologies, secures those technologies through licensing agreements with the patent holders, and converts the technologies into viable products that it then produces and sells.
Medra Corporation Fundamentals Summary
MDRA fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | -US$7.91m |
Revenue (TTM) | US$1.13m |
0.0x
P/S Ratio0.0x
P/E RatioIs MDRA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MDRA income statement (TTM) | |
---|---|
Revenue | US$1.13m |
Cost of Revenue | US$1.45m |
Gross Profit | -US$321.95k |
Other Expenses | US$7.59m |
Earnings | -US$7.91m |
Last Reported Earnings
Jun 30, 2002
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MDRA perform over the long term?
See historical performance and comparison